← Leaderboards
Timothy J Sellati
University Of Connecticut Sch Of Med/Dnt
$4,424,053
Attributed
$5,981,410
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $729K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,981,410 · 5
By mechanism
R01$5,601,102 · 3
P01$357,840 · 1
F32$22,468 · 1
Top collaborators
- Edmund J Gosselin4 shared
- Karsten R.O. Hazlett4 shared
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Justin D. Radolf$26,431,208
- Melissa J Caimano$3,921,700
- Juan C Salazar$8,767,171
- Peter James Krause$2,079,888
- Charles W Wolgemuth$2,200,754
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenImmuneCellsPathogenesisResponseBacteriaInfectionBaseFrancisella TularensisMediatingVirulentInvestigationMacrophageBiothreatCategoriesSeveritiesSignal TransductionCytokineTherapeutic InterventionInflammationFlow CytometryAntigensInflammatoryNeutrophil
Grant awards (15)
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting$584,009
R01 · FY2016 · AI
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting$584,009
R01 · FY2015 · AI
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting$584,009
R01 · FY2014 · AI
Criteria-Directed Vaccine Generation Via Ag Mimicry, Adjuvancy, And APC-Targeting$584,009
R01 · FY2013 · AI
TLR2/NLR Signal Regulation of Protective Immunity to F. Tularensis$357,840
P01 · FY2012 · AI · contact PI
Modulating MMP-9 and Neutrophil Recruitment: A Therapeutic Strategy for Tularemia$376,456
R01 · FY2011 · AI · contact PI
Modulating MMP-9 and Neutrophil Recruitment: A Therapeutic Strategy for Tularemia$380,259
R01 · FY2010 · AI · contact PI
Modulating MMP-9 and Neutrophil Recruitment: A Therapeutic Strategy for Tularemia$384,100
R01 · FY2009 · AI · contact PI
Modulating MMP-9 and Neutrophil Recruitment: A Therapeutic Strategy for Tularemia$398,350
R01 · FY2008 · AI · contact PI
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASE$330,675
R01 · FY2008 · AI · contact PI
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASE$337,079
R01 · FY2007 · AI · contact PI
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASE$347,147
R01 · FY2006 · AI · contact PI
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASE$355,500
R01 · FY2005 · AI
CD14 AND THE IMMUNOPATHOGENESIS OF CHRONIC LYME DISEASE$355,500
R01 · FY2004 · AI
MACROPHAGE ACTIVATION BY SPIROCHETAL LIPOPROTEINS$22,468
F32 · FY2000 · AI